Regeneron Pharmaceuticals Takes Over #146 Spot From Arthur J. Gallagher
March 27, 2023 at 12:37 PM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Regeneron Pharmaceuticals, Inc. (REGN) has taken over the #146 spot from Arthur J..